Cunningham, YvonneWood, KarenStewart, CarrieNakham, AthagranNewlands, RumanaGallacher, Katie I.Quinn, Terence JEllis, GrahamLowrie, RichardMyint, Phyo KyawBond, ChristineMair, Frances S.2022-01-062022-01-062021-11-12Cunningham, Y, Wood, K, Stewart, C, Nakham, A, Newlands, R, Gallacher, K I, Quinn, T J, Ellis, G, Lowrie, R, Myint, P K, Bond, C & Mair, F S 2021, 'Understanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden : a qualitative study', Frontiers in Pharmacology, vol. 12, 608208. https://doi.org/10.3389/fphar.2021.6082081663-9812PubMedCentral: PMC8633300ORCID: /0000-0003-3852-6158/work/163198557ORCID: /0000-0003-4563-152X/work/169078779https://hdl.handle.net/2164/17796Funding statement This research was supported by the Chief Scientist Office under their Catalytic Research Grants Scheme, CSO reference number: CGA/18/47. Acknowledgments We gratefully acknowledge the support from the Alliance, the Glasgow Stroke Group and NKS in recruiting focus group participants and conducting the focus groups and Scottish Primary Care Research Network for recruiting patients from primary care. Special thanks to Irene Oldfather from Alliance and Naseem Suleman from NKS for their help in setting up interviews and focus groups. We gratefully acknowledge the research participants who provided their views and insights.10632842enganticholinergicsDeprescribingPolypharmacyinterviewsFocus GroupsQualitative ResearchR MedicineChief Scientist Office (CSO)CGA/18/47Supplementary InformationRJournal article10.3389/fphar.2021.60820812